Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staccato Loxapine in Agitated Patients With Schizophrenia
NCT00628589Phase 3Completed
- Sponsor
- Alexza Pharmaceuticals Inc
- Start
- Feb 2008
- Primary completion
- May 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of loxapine in schizophrenia, sponsored by Alexza Pharmaceuticals Inc. Started Feb 2008; status: completed.
02
Drugs
loxapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00628589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628589.